Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by TheGrapeApe2020on May 07, 2020 8:05pm
182 Views
Post# 31000805

RE:RE:When do we realistically expect to see $20?

RE:RE:When do we realistically expect to see $20?2021 fall or 2022 winter but all depends on how much Germany has been affected by the virus 

Only way they will survive is to raise funds which will Dilute the shares  it will hurt for a while but should pay off long term if they can strike a good deal.

Have to remember this company does not have the best record with the big finace players.

Trying to compare to CGC only in the metrics you have used is dangours as you are not taking a lot in to consideration.  Not a good way to invest.  look at the company it self forget the competitors exsist and then ask wold you buy it?  Trying to compare any weed comapies is useless because they are all differant and on differant paths



ProfCornelius wrote:
PuffnPass13 wrote:

Hey guys,

im not new to the industry and unfortunately I lost a lot of money in small players in the cannabis sector and with the remainder I've went all in on APHA!

I always knew APHA would be one of the top LPs but after seeing their Q3 I can't believe this is trading at only x2.5 f/e with market cap of 1.4 vs cgc at 8 so I know we have an undervalued stock.

the question is how long realistically do you guys think it will take for apha to be at $20 again? That would mean it would have a 5.6 billion market cap (still lower than cgc currently).

i know cgc and cronos have larger cash position than us but that's thanks to their corporate sponsorship, which both have mistimed getting into the industry and over-paying.

serious comments only no bs. Thanks 


Fall 2021 IF Aphria doesn't get taken out first and there is a vaccine for COVID 19.

As I have stated earlier, there is a race.
Scientists need to create the vaccine before the virus mutates too much for the vaccine to be effective .Otherwise, we start all over again...

Prof





<< Previous
Bullboard Posts
Next >>